Profile
| Metric | Value |
|---|---|
| Full Name | Nuvation Bio Inc. |
| Ticker | NYSE: NUVB |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nuvationbio.com |
| Employees | 273 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $8.84 | |
| Price, 1D Change | +4.12% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.29 | |
| Revenue | $8M | |
| Revenue, 1Y Change | +100.00% | |
| EPS | -$2.11 | |
| EPS, 1Y Change | -510.19% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | PANA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$2.11 | |
| EPS Estimate | -$0.45 | |
| EPS Est. Change | +78.70% | |
| Revenue | $7.87M | |
| Revenue Estimate | $54.54M | |
| Revenue Est. Change | +592.79% | |
| Current Price | $8.84 | |
| Price Target | - | $10.50 |
| Price Tgt. Change | - | +18.78% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.39 | -$0.35 | +11.21% | |
| -$2.07 | -$2.11 | -2.33% | |
| -$0.45 | N/A | +78.70% | |
| -$0.28 | N/A | +86.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $2.17M | $7.87M | +262.88% | |
| $54.54M | N/A | +592.79% | |
| $173.75M | N/A | +2,106.90% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +172.00% | |
| Price, 3Y | +344.22% | |
| Market Cap, 1Y | +176.02% | |
| Market Cap, 3Y | +596.57% | |
| Revenue, 1Y | +100.00% | |
| Revenue, 3Y | +100.00% | |
| EPS, 1Y | -510.19% | |
| EPS, 3Y | -381.45% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $8.84 | |
| SMA 200 | $3.73 | |
| SMA 200 vs Price | -57.82% | |
| SMA 50 | $7.24 | |
| SMA 50 vs Price | -18.13% | |
| Beta | 1.29 | |
| ATR | $0.49 | |
| 14-Day RSI | 58.28 | |
| 10-Day Volatility | 39.66% | |
| 1-Year Volatility | 92.88% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $7.87M | |
| EPS | -$2.11 | |
| Gross Profit | $112.00K | |
| Gross Margin | 1.42% | |
| Operating Profit | -$592.63M | |
| Operating Margin | -2,128.25% | |
| Net Income | -$567.94M | |
| Net Margin | -7,213.76% | |
| EBITDA | -$566.92M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.02 | |
| Current Ratio | 9.04 | |
| Quick Ratio | 9.04 | |
| - | ||
| F-Score | 3 | |
| Altman Z-Score | 18.90 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 113.30 | |
| PB Ratio | 9.30 | |
| EV/EBITDA | -11.62 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $463.79M | |
| Cash & Equivalents | $35.72M | |
| Total Assets | $540.63M | |
| Current Assets | $526.26M | |
| Total Liabilities | $76.84M | |
| Current Liabilities | $58.24M | |
| Total Debt | $8.92M | |
| Short Term Debt | $7.95M | |
| Accounts Payable | $6.35M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $600.50M | |
| Operating Expenses | $593.42M | |
| Cost Of Goods Sold | $7.76M | |
| SG&A | $69.23M | |
| D&A | $683.00K | |
| Interest Expense | $0.00 | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$130.41M | |
| CFI | $122.70M | |
| CFF | $331.00K | |
| Capex | $162.00K | |
| Free Cash Flow | -$130.58M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Truist Securities | ||
| Citizens | → | |
| B. Riley Securities | ||
| RBC Capital | → | |
| Citizens | → | |
| Wedbush | → | |
| Jefferies | ||
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with NUVB
Data Sources & References
- NUVB Official Website www.nuvationbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1811063/000119312525262605/0001193125-25-262605-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1811063/000095017025034903/0000950170-25-034903-index.htm
- NUVB Profile on Yahoo Finance finance.yahoo.com/quote/NUVB
- NUVB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nuvb
FAQ
What is the ticker symbol for Nuvation Bio Inc.?
The ticker symbol for Nuvation Bio Inc. is NYSE:NUVB
Does Nuvation Bio Inc. pay dividends?
No, Nuvation Bio Inc. does not pay dividends
What sector is Nuvation Bio Inc. in?
Nuvation Bio Inc. is in the Healthcare sector
What industry is Nuvation Bio Inc. in?
Nuvation Bio Inc. is in the Biotechnology industry
What country is Nuvation Bio Inc. based in?
Nuvation Bio Inc. is headquartered in United States
When did Nuvation Bio Inc. go public?
Nuvation Bio Inc. initial public offering (IPO) was on August 26, 2020
Is Nuvation Bio Inc. in the S&P 500?
No, Nuvation Bio Inc. is not included in the S&P 500 index
Is Nuvation Bio Inc. in the NASDAQ 100?
No, Nuvation Bio Inc. is not included in the NASDAQ 100 index
Is Nuvation Bio Inc. in the Dow Jones?
No, Nuvation Bio Inc. is not included in the Dow Jones index
When was Nuvation Bio Inc. last earnings report?
Nuvation Bio Inc.'s most recent earnings report was on November 3, 2025
When does Nuvation Bio Inc. report earnings?
The next expected earnings date for Nuvation Bio Inc. is March 5, 2026